SPXU vs. LABD
SPXU (ProShares UltraPro Short S&P500) and LABD (Direxion Daily S&P Biotech Bear 3x Shares) are both Leveraged Equities funds - SPXU tracks the S&P 500 Index (-300%) while LABD tracks the S&P Biotechnology Select Industry Index (-300%). Both are passively managed. Over the past 10 years, SPXU returned -41.95%/yr vs -56.11%/yr for LABD. A 0.57 correlation means they provide meaningful diversification when combined. SPXU charges 0.93%/yr vs 1.06%/yr for LABD.
Performance
SPXU vs. LABD - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SPXU achieves a -25.62% return, which is significantly higher than LABD's -29.83% return. Over the past 10 years, SPXU has outperformed LABD with an annualized return of -41.95%, while LABD has yielded a comparatively lower -56.11% annualized return.
SPXU
- 1D
- 2.06%
- 1M
- -13.20%
- YTD
- -25.62%
- 6M
- -25.04%
- 1Y
- -48.96%
- 3Y*
- -43.02%
- 5Y*
- -34.89%
- 10Y*
- -41.95%
LABD
- 1D
- -4.73%
- 1M
- 4.70%
- YTD
- -29.83%
- 6M
- -31.22%
- 1Y
- -80.27%
- 3Y*
- -49.85%
- 5Y*
- -41.45%
- 10Y*
- -56.11%
SPXU vs. LABD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SPXU ProShares UltraPro Short S&P500 | -25.62% | -41.73% | -43.31% | -46.02% | 36.05% | -57.94% | -70.39% | -56.27% | 3.97% | -44.23% |
LABD Direxion Daily S&P Biotech Bear 3x Shares | -29.83% | -70.07% | -21.43% | -41.77% | -32.68% | 1.86% | -89.75% | -70.80% | -6.26% | -75.67% |
Correlation
The correlation between SPXU and LABD is 0.51, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.51 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.54 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.57 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.57 |
Correlation (All Time) Calculated using the full available price history since May 29, 2015 | 0.57 |
The correlation between SPXU and LABD has been stable across timeframes, ranging from 0.51 to 0.57 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SPXU vs. LABD — Risk / Return Rank
SPXU
LABD
SPXU vs. LABD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ProShares UltraPro Short S&P500 (SPXU) and Direxion Daily S&P Biotech Bear 3x Shares (LABD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| SPXU | LABD | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.33 | ||
| Sortino ratioReturn per unit of downside risk | -0.11 | ||
| Omega ratioGain probability vs. loss probability | 0.75 | 0.75 | 0.00 |
| Calmar ratioReturn relative to maximum drawdown | -0.97 | -0.97 | 0.00 |
| Martin ratioReturn relative to average drawdown | -1.63 | -1.31 | -0.32 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| SPXU | LABD | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -1.39 | -1.06 | -0.33 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.70 | -0.43 | -0.26 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.79 | -0.59 | -0.20 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.84 | -0.54 | -0.30 |
Drawdowns
SPXU vs. LABD - Drawdown Comparison
The maximum SPXU drawdown since its inception was -99.99%, roughly equal to the maximum LABD drawdown of -99.99%. Use the drawdown chart below to compare losses from any high point for SPXU and LABD.
Loading charts...
Drawdown Indicators
| SPXU | LABD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.99% | -99.99% | 0.00% |
Max Drawdown (1Y)Largest decline over 1 year | -50.82% | -83.21% | +32.39% |
Max Drawdown (3Y)Largest decline over 3 years | -84.36% | -95.31% | +10.95% |
Max Drawdown (5Y)Largest decline over 5 years | -90.23% | -98.24% | +8.01% |
Max Drawdown (10Y)Largest decline over 10 years | -99.63% | -99.98% | +0.35% |
Current DrawdownCurrent decline from peak | -99.99% | -99.99% | 0.00% |
Average DrawdownAverage peak-to-trough decline | -93.33% | -90.92% | -2.41% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 30.06% | 61.36% | -31.30% |
Volatility
SPXU vs. LABD - Volatility Comparison
The current volatility for ProShares UltraPro Short S&P500 (SPXU) is 8.58%, while Direxion Daily S&P Biotech Bear 3x Shares (LABD) has a volatility of 27.46%. This indicates that SPXU experiences smaller price fluctuations and is considered to be less risky than LABD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SPXU | LABD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.58% | 27.46% | -18.88% |
Volatility (6M)Calculated over the trailing 6-month period | 26.85% | 61.67% | -34.82% |
Volatility (1Y)Calculated over the trailing 1-year period | 35.37% | 75.77% | -40.40% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 50.33% | 96.26% | -45.93% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 53.38% | 95.93% | -42.55% |
SPXU vs. LABD - Expense Ratio Comparison
SPXU has a 0.93% expense ratio, which is lower than LABD's 1.06% expense ratio.
Dividends
SPXU vs. LABD - Dividend Comparison
SPXU's dividend yield for the trailing twelve months is around 7.89%, more than LABD's 6.45% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
LABD Direxion Daily S&P Biotech Bear 3x Shares | 6.45% | 6.67% | 4.68% | 6.13% | 0.53% | 0.00% | 3.94% | 1.75% | 0.81% | 0.00% |
SPXU ProShares UltraPro Short S&P500 | 7.89% | 7.02% | 9.53% | 7.06% | 0.39% | 0.00% | 0.70% | 2.14% | 1.41% | 0.10% |
Frequently Asked Questions
SPXU and LABD have a correlation of 0.51, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
LABD has higher volatility (27.46%) compared to SPXU (8.58%). In terms of maximum drawdown, SPXU dropped -99.99% vs LABD's -99.99%.
On 10-year performance, SPXU leads with -41.95% vs -56.11% for LABD. On fees, SPXU is cheaper at 0.93% per year. On volatility, SPXU has been the lower-risk option at 8.58%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, SPXU has performed better with a -41.95% return vs -56.11%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
SPXU is cheaper with a 0.93% expense ratio, compared with 1.06% for LABD.
SPXU has the higher dividend yield at 7.89%, compared with 6.45% for LABD.
SPXU tracks S&P 500 Index (-300%), while LABD tracks S&P Biotechnology Select Industry Index (-300%). They also come from different issuers: ProShares and Direxion. Their fees differ too: 0.93% for SPXU and 1.06% for LABD.
LABD currently has the higher Sharpe Ratio (-1.06 vs -1.39), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SPXU and LABD
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer